VSTM übertreffen die 20 der letzten 40Schätzungen.
50%
Nächster Bericht
Datum des nächsten Berichts
18. März 2026
Estimate forQ4 25(Revenue/ EPS)
$16.61M
/
-$0.55
Implizierte Änderung vonQ3 25(Revenue/ EPS)
+47.79%
/
-59.26%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
--
/
-58.65%
Verastem, Inc. earnings per share and revenue
On 04. Nov. 2025, VSTM reported earnings of -1.35 USD per share (EPS) for Q3 25, missing the estimate of -0.64 USD, resulting in a -108.20% surprise. Revenue reached 11.24 million, compared to an expected 5.77 million, with a 94.75% difference. The market reacted with a -20.10% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.55 USD, with revenue projected to reach 16.61 million USD, implying an decrease of -59.26% EPS, and increase of 47.79% in Revenue from the last quarter.
FAQ
What were Verastem, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Verastem, Inc. reported EPS of -$1.35, missing estimates by -108.2%, and revenue of $11.24M, 94.75% above expectations.
How did the market react to Verastem, Inc.'s Q3 2025 earnings?
The stock price moved down -20.1%, changed from $9.90 before the earnings release to $7.91 the day after.
When is Verastem, Inc. expected to report next?
The next earning report is scheduled for 18. März 2026.
What are the forecasts for Verastem, Inc.'s next earnings report?
Based on 11
analysts, Verastem, Inc. is expected to report EPS of -$0.55 and revenue of $16.61M for Q4 2025.